• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Skystar Bio Pharmaceutical Company (SKBI)

    -NasdaqCM
    4.45 Down 0.13(2.84%) 3:58PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 18,353   14,240   6,833   9,625  
    Cost of Revenue9,590  7,881  4,009  4,906  
    Gross Profit 8,763   6,359   2,823   4,720  
    Operating Expenses
    Research Development378  799  4  538  
    Selling General and Administrative2,985  2,192  1,647  1,523  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 5,400   3,368   1,172   2,659  
    Income from Continuing Operations
    Total Other Income/Expenses Net475  262  309  322  
    Earnings Before Interest And Taxes5,875  3,630  1,481  2,981  
    Interest Expense252  137  76  47  
    Income Before Tax5,622  3,493  1,405  2,934  
    Income Tax Expense713  682  430  601  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops4,909  2,811  975  2,332  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 4,909   2,811   975   2,332  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 4,909   2,811   975   2,332  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.